RUBEN HERNAEZ to Carcinoma, Hepatocellular
This is a "connection" page, showing publications RUBEN HERNAEZ has written about Carcinoma, Hepatocellular.
Connection Strength
5.273
-
Benefits and harms of hepatocellular carcinoma screening outreach in patients with cirrhosis: a multicenter randomized clinical trial. J Natl Cancer Inst. 2025 Feb 01; 117(2):262-269.
Score: 0.511
-
Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial. Gut. 2024 Nov 11; 73(12):2037-2044.
Score: 0.503
-
Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: cui bono? Gut. 2023 01; 72(1):7-9.
Score: 0.422
-
MAFLD, HCC and the dilemma of (changing) terminology in liver diseases. Gut. 2023 01; 72(1):9-11.
Score: 0.416
-
Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance. Clin Gastroenterol Hepatol. 2022 12; 20(12):2818-2825.e1.
Score: 0.411
-
End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma. Gut. 2022 03; 71(3):454-456.
Score: 0.392
-
Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021 05; 19(5):987-995.e1.
Score: 0.372
-
Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis. Hepatology. 2018 07; 68(1):7-9.
Score: 0.321
-
How we approach it: treatment options for hepatocellular carcinoma. Am J Gastroenterol. 2018 06; 113(6):791-794.
Score: 0.320
-
Hepatocellular carcinoma surveillance: The road ahead. Hepatology. 2017 03; 65(3):771-773.
Score: 0.294
-
?Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study. Ann Hepatol. 2017 Jan-Feb 2017; 16(1):16-20.
Score: 0.292
-
Access to Evaluation for Liver Transplantation in the Veterans Health Administration. Dig Dis Sci. 2025 Feb; 70(2):552-565.
Score: 0.127
-
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass. Oncology (Williston Park). 2023 08 08; 37(8):335-338.
Score: 0.115
-
Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2024 Apr; 22(4):760-767.e1.
Score: 0.115
-
Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis. Hepatology. 2024 01 01; 79(1):107-117.
Score: 0.115
-
Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy. Liver Transpl. 2023 10 01; 29(10):1138-1142.
Score: 0.113
-
Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes. Dig Dis Sci. 2023 01; 68(1):312-322.
Score: 0.107
-
Using Telemedicine to Facilitate Patient Communication and Treatment Decision-Making Following Multidisciplinary Tumor Board Review for Patients with Hepatocellular Carcinoma. J Gastrointest Cancer. 2023 Jun; 54(2):623-631.
Score: 0.107
-
The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States. Clin Gastroenterol Hepatol. 2023 02; 21(2):415-423.e4.
Score: 0.104
-
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2020 04; 18(4):974-983.
Score: 0.087
-
Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.
Score: 0.029